Understanding the immune response to tick-borne infections

At the site of the bite: Immune Response to tick-transmitted Rickettsiae

['FUNDING_R01'] · TUFTS UNIVERSITY BOSTON · NIH-11046055

This study is looking at how our immune system reacts to infections from certain tick-borne germs, using guinea pigs to mimic the disease, so we can learn more about how to better diagnose and treat people who get sick from these infections.

Quick facts

Phase['FUNDING_R01']
Study typeNih_funding
SexAll
SponsorTUFTS UNIVERSITY BOSTON (nih funded)
Locations1 site (BOSTON, UNITED STATES)
Trial IDNIH-11046055 on ClinicalTrials.gov

What this research studies

This research investigates how the human immune system responds to infections caused by tick-transmitted Rickettsia species, specifically focusing on spotted fever rickettsiosis. Using guinea pigs as a model, the study aims to replicate the disease after tick bites, allowing researchers to collect blood samples over time to analyze immune responses. The approach includes examining different Rickettsia species that vary in their potential to cause severe illness in humans, which could lead to better diagnostic and treatment strategies for affected patients.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals who have been bitten by ticks and are experiencing symptoms related to spotted fever rickettsiosis.

Not a fit: Patients who have not been exposed to ticks or do not exhibit symptoms of tick-borne diseases may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could enhance our understanding of tick-borne diseases and improve diagnosis and treatment options for patients suffering from these infections.

How similar studies have performed: Previous research using animal models to study tick-borne diseases has shown promise, indicating that this approach could yield valuable insights.

Where this research is happening

BOSTON, UNITED STATES

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.

View on NIH RePORTER →

Conditions: Acute Disease, acute disease/disorder, acute disorder, acute infection

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.